SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-16-462082
Filing Date
2016-02-12
Accepted
2016-02-12 15:15:31
Documents
3
Group Members
BAXALTA GMBH

Document Format Files

Seq Description Document Type Size
1 SC 13G d135796dsc13g.htm SC 13G 53506
2 EX-99.1 d135796dex991.htm EX-99.1 4195
3 EX-99.2 d135796dex992.htm EX-99.2 7006
  Complete submission text file 0001193125-16-462082.txt   66359
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48459 | Film No.: 161418278
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015 224-940-2000
Baxalta Inc (Filed by) CIK: 0001620546 (see all company filings)

IRS No.: 471869689 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations